Data / Drug companies / Macrolide Antimicrobial
Macrolide Antimicrobial drugs: 9 drugs from 89 companies in the FDA NDC directory
Macrolide Antimicrobial is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 365 products in this class from 89 companies, covering 9 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 28, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 89Companies
- 365Products
- 9Drugs by generic name
Drugs in the Macrolide Antimicrobial class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Azithromycin | 139 | 41 |
| Erythromycin | 81 | 36 |
| Clarithromycin | 54 | 27 |
| Azithromycin dihydrate | 53 | 20 |
| Erythromycin ethylsuccinate | 22 | 8 |
| Azithromycin monohydrate | 10 | 7 |
| Erythromycin lactobionate | 4 | 4 |
| Erythromycin and benzoyl peroxide | 1 | 3 |
| Erythromycin topical solution 2% | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 28 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | January 16, 2026 |
| NuCare Pharmaceuticals,Inc. | 20 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | February 15, 2024 |
| Remedyrepack Inc. | 13 | tablet, film coated; ointment | Generic drugs (ANDA) | June 23, 2026 |
| Azurity Pharmaceuticals, Inc. | 12 | tablet, delayed release; suspension | Generic drugs (ANDA) | June 14, 2012 |
| Preferred Pharmaceuticals Inc. | 11 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | January 1, 2025 |
| Proficient Rx LP | 11 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | July 1, 2019 |
| Asclemed USA, Inc. | 9 | tablet, film coated; ointment | Generic drugs (ANDA) | April 11, 2022 |
| Sportpharm LLC | 9 | tablet, film coated; ointment | Generic drugs (ANDA) | February 15, 2024 |
| Wilshire Pharmaceuticals, Inc. | 9 | tablet, delayed release; suspension | Generic drugs (ANDA) | August 24, 2020 |
| Pfizer Laboratories Div Pfizer Inc | 8 | powder, for suspension; tablet, film coated | New drug applications (NDA) | May 17, 2019 |
| Alembic Pharmaceuticals Inc. | 7 | tablet, film coated | Generic drugs (ANDA) | August 28, 2023 |
| Alembic Pharmaceuticals Limited | 7 | tablet, film coated | Generic drugs (ANDA) | August 28, 2023 |
| Bryant Ranch Prepack | 7 | tablet, film coated; for suspension | Generic drugs (ANDA) | November 21, 2022 |
| Direct_Rx | 7 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | August 5, 2025 |
| Proficient Rx LP | 7 | tablet, film coated; ointment | Generic drugs (ANDA) | December 4, 2015 |
| Redpharm Drug | 7 | tablet, film coated; ointment | Generic drugs (ANDA) | April 1, 2026 |
| Sandoz Inc | 7 | tablet, film coated; tablet | Generic drugs (ANDA) | September 4, 2007 |
| Coupler LLC | 6 | tablet, film coated; tablet | Generic drugs (ANDA) | October 28, 2026 |
| Zydus Lifesciences Limited | 6 | powder, for suspension; tablet, film coated | Generic drugs (ANDA) | June 30, 2023 |
| Zydus Pharmaceuticals USA Inc. | 6 | powder, for suspension; tablet, film coated | Generic drugs (ANDA) | June 30, 2023 |
| Advanced Rx of Tennessee, LLC | 5 | tablet, film coated; tablet | Generic drugs (ANDA) | August 27, 2024 |
| Amneal Pharmaceuticals NY LLC | 5 | tablet, delayed release; suspension | Generic drugs (ANDA) | November 4, 2019 |
| Chartwell RX, LLC | 5 | tablet, film coated; suspension | Generic drugs (ANDA) | September 10, 2019 |
| Lannett Company, Inc. | 5 | tablet, film coated; tablet, film coated, extended release | Generic drugs (ANDA) | November 23, 2019 |
| Proficient Rx LP | 5 | tablet, film coated; tablet | Generic drugs (ANDA) | February 15, 2024 |
| Slate Run Pharmaceuticals, LLC | 5 | powder, for suspension; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | January 1, 2024 |
| Torrent Pharmaceuticals Limited | 5 | tablet, delayed release; tablet, coated | Generic drugs (ANDA) | October 21, 2024 |
| Aurobindo Pharma Limited | 4 | tablet, film coated | Generic drugs (ANDA) | July 5, 2018 |
| Bryant Ranch Prepack | 4 | gel; swab | Generic drugs (ANDA) | July 5, 2018 |
| Bryant Ranch Prepack | 4 | tablet, film coated; tablet | Generic drugs (ANDA) | February 15, 2024 |
| Cadila Pharmaceuticals Limited | 4 | tablet, film coated; for suspension | Generic drugs (ANDA) | November 21, 2022 |
| Epic Pharma, LLC | 4 | powder, for suspension | Generic drugs (ANDA) | April 10, 2018 |
| Golden State Medical Supply, Inc. | 4 | tablet, coated; tablet, delayed release | Generic drugs (ANDA) | July 26, 2021 |
| PD-Rx Pharmaceuticals, Inc. | 4 | tablet, film coated; tablet, film coated, extended release | Generic drugs (ANDA) | November 23, 2019 |
| Teva Pharmaceuticals USA, Inc. | 4 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | May 4, 2021 |
| Zhejiang Poly Pharm. Co., Ltd. | 4 | powder, for suspension | Generic drugs (ANDA) | April 11, 2025 |
| American Health Packaging | 3 | tablet, film coated | Generic drugs (ANDA) | August 1, 2023 |
| Ani Pharmaceuticals, Inc. | 3 | granule, for suspension | Generic drugs (ANDA) | March 25, 2019 |
| AvKARE | 3 | tablet, film coated | Generic drugs (ANDA) | April 24, 2024 |
| AvPAK | 3 | tablet, film coated | Generic drugs (ANDA) | December 11, 2020 |
| Bionpharma Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | March 12, 2019 |
| Lupin Pharmaceuticals, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | November 17, 2022 |
| Major Pharmaceuticals | 3 | tablet, film coated | Generic drugs (ANDA) | May 1, 2023 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | February 15, 2024 |
| Padagis Israel Pharmaceuticals Ltd | 3 | gel; swab | Generic drugs (ANDA) | December 19, 2011 |
| Precision Dose, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | February 15, 2024 |
| Puracap Laboratories LLC DBA Blu Pharmaceuticals | 3 | powder, for suspension | Generic drugs (ANDA) | May 30, 2025 |
| Rising Pharma Holdings, Inc. | 3 | tablet, film coated; gel | Generic drugs (ANDA) | June 3, 2026 |
| Solaris Pharma Corporation | 3 | tablet, film coated; tablet, film coated, extended release | Generic drugs (ANDA) | November 23, 2019 |
| Teva Pharmaceuticals USA, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | January 6, 2006 |
| AiPing Pharmaceutical, Inc. | 2 | powder, for suspension | Generic drugs (ANDA) | January 16, 2026 |
| Amneal Pharmaceuticals NY LLC | 2 | suspension | Generic drugs (ANDA) | December 2, 2023 |
| Armas Pharmaceuticals Inc. | 2 | injection, powder, lyophilized, for solution; ointment | Generic drugs (ANDA) | July 9, 2026 |
| Ascend Laboratories, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | July 14, 2022 |
| Athenex Pharmaceutical Division, LLC. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | August 30, 2019 |
| Aurobindo Pharma Limited | 2 | powder, for suspension | Generic drugs (ANDA) | October 9, 2018 |
| Cardinal Health 107, LLC | 2 | ointment; tablet, film coated | Generic drugs (ANDA) | July 2, 2024 |
| Fresenius Kabi USA, LLC | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | March 20, 2006 |
| Gland Pharma Limited | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 19, 2024 |
| Kanchan Healthcare Inc | 2 | for suspension | Generic drugs (ANDA) | November 21, 2022 |
| Modavar Pharmaceuticals LLC | 2 | tablet, film coated | Generic drugs (ANDA) | July 31, 2021 |
| Nivagen Pharmaceuticals, Inc. | 2 | suspension | Generic drugs (ANDA) | February 1, 2023 |
| Orange Pharmaceuticals USA LLC | 2 | tablet, film coated | Generic drugs (ANDA) | October 5, 2019 |
| Rising Pharma Holdings, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | July 25, 2012 |
| Sagent Pharmaceuticals | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | August 1, 2025 |
| State Health Services, Texas Department of | 2 | powder, for suspension | Generic drugs (ANDA) | December 28, 2010 |
| Actavis Pharma, Inc. | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | February 27, 2014 |
| American Health Packaging | 1 | tablet, film coated | Generic drugs (ANDA) | March 4, 2026 |
| Bausch & Lomb Incorporated | 1 | ointment | Generic drugs (ANDA) | July 29, 1994 |
| Direct RX | 1 | ointment | Generic drugs (ANDA) | January 1, 2014 |
| Doc Rx | 1 | tablet, film coated | Generic drugs (ANDA) | March 12, 2019 |
| Dr. Reddy's Laboratories Inc. | 1 | capsule, delayed release pellets | Authorized generics (NDA) | September 1, 2024 |
| Eugia US LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 19, 2015 |
| Fera Pharmaceuticals, LLC | 1 | ointment | Unapproved drugs for a shortage | September 27, 2023 |
| Health Department, Oklahoma State | 1 | tablet, film coated | Generic drugs (ANDA) | February 15, 2024 |
| Hospira, Inc. | 1 | injection, powder, lyophilized, for solution | New drug applications (NDA) | May 25, 2005 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | April 3, 2023 |
| Northwind Health Company, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | August 13, 2025 |
| NuCare Pharmaceuticals, Inc. | 1 | ointment | Generic drugs (ANDA) | July 29, 1994 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | September 6, 2011 |
| PharmPak, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | July 10, 2019 |
| Piramal Critical Care Inc | 1 | injection, powder, for solution | Generic drugs (ANDA) | August 13, 2026 |
| Quality Care Products, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | August 28, 2024 |
| Saptalis Pharmaceuticals, LLC. | 1 | solution | Generic drugs (ANDA) | August 14, 2024 |
| Sentiss Pharmaceuticals LLC | 1 | ointment | Generic drugs (ANDA) | April 1, 2026 |
| St. Mary's Medical Park Pharmacy | 1 | ointment | Generic drugs (ANDA) | October 18, 2023 |
| Sun Pharmaceutical Industries, Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | March 27, 2023 |
| Tagi Pharma, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | July 1, 2019 |
| Thea Pharma Inc. | 1 | solution/ drops | New drug applications (NDA) | November 1, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 189 | 51.8% |
| Powder, for suspension | 55 | 15.1% |
| Ointment | 23 | 6.3% |
| Tablet | 16 | 4.4% |
| Injection, powder, lyophilized, for solution | 15 | 4.1% |
| Tablet, delayed release | 14 | 3.8% |
| Suspension | 12 | 3.3% |
| For suspension | 9 | 2.5% |
| Granule, for suspension | 7 | 1.9% |
| Gel | 5 | 1.4% |
| Tablet, film coated, extended release | 5 | 1.4% |
| Solution | 4 | 1.1% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.